Celia Jacoberger-Foissac

3PUBLICATIONS
34CO-AUTHORS
Human impacts of climate change and human adaptationMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 23, 2023
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

Michael C Warren, Stephan Matissek, Matthew Rausch

|Nov 21, 2022
CD73 Inhibits cGAS-STING and Cooperates with CD39 to Promote Pancreatic Cancer.

Célia Jacoberger-Foissac, Isabelle Cousineau, Yacine Bareche

|Apr 27, 2022
Addition of interleukin-2 overcomes resistance to neoadjuvant CTLA4 and PD1 blockade in ex vivo patient tumors.

Paulien Kaptein, Celia Jacoberger-Foissac, Petros Dimitriadis

Pageof 1